Workflow
Ultragenyx (RARE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
RAREUltragenyx Pharmaceutical(RARE) ZACKS·2025-02-13 23:30

For the quarter ended December 2024, Ultragenyx (RARE) reported revenue of 164.88million,up29.4164.88 million, up 29.4% over the same period last year. EPS came in at -1.39, compared to -1.52intheyearagoquarter.ThereportedrevenuecomparestotheZacksConsensusEstimateof1.52 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of 163.23 million, representing a surprise of +1.01%. The company delivered an EPS surprise of -12.10%, with the consensus EPS estimate being -$1.24.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- a ...